Literature DB >> 11774739

Mitochondria in platinum resistant cells.

S Isonishi1, M Saitou, M Yasuda, T Tanaka.   

Abstract

Based on the previous report showing that mitochondrial (MT) alteration is associated with platinum (Pt) resistance, we have determined how the alternative MT function is involved in Pt cell cytotoxicity particularly in relation to the apoptosis. MT membrane potential (delta psi m) semi-quantitatively assessed by rhodamin 123 (Rh) sensitivity was significantly elevated in acquired Pt-resistant 2008/C13*5.25 cells (C13) established from its parental 2008 cells or known intrinsic Pt-resistant JHOC cells established from ovarian clear cell adenocarcinoma. Laser confocal microscopy of these cells stained with Rh revealed that MT in Pt-resistant cells were distributed in whole cytoplasm with relatively higher fluorescent intensity whereas MT in Pt-sensitive cells were localized in perinuclear space with lower fluorescent intensity. Electron microscopy showed the predominantly condensed MT in which crestal structure was not observed clearly in Pt-resistant cells. Western blot analysis using murine monoclonal anti-Bcl-2 antibody showed more than 5-fold Bcl-2 overexpression in Pt-resistant cells in response to cisplatin treatment. Cytochrome C (CytC) in MT was released from MT into cytoplasm in response to cisplatin treatment in Pt-sensitive cells, whereas up-regulation of CytC level in MT rather than CytC release from MT was observed in Pt-resistant cells. These data are strongly suggesting that changes at MT level would impact on the relative resistance of malignant cells to undergo drug-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11774739

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  6 in total

1.  Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.

Authors:  Irina Buß; Ganna V Kalayda; Andreas Lindauer; Michael R Reithofer; Markus Galanski; Bernhard K Keppler; Ulrich Jaehde
Journal:  J Biol Inorg Chem       Date:  2012-03-29       Impact factor: 3.358

2.  Targeting mitochondrial DNA with a platinum-based anticancer agent.

Authors:  Simon P Wisnovsky; Justin J Wilson; Robert J Radford; Mark P Pereira; Maria R Chan; Rebecca R Laposa; Stephen J Lippard; Shana O Kelley
Journal:  Chem Biol       Date:  2013-10-31

Review 3.  Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.

Authors:  Kevin J Cullen; Zejia Yang; Lisa Schumaker; Zhongmin Guo
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

4.  Cisplatin cytotoxicity is dependent on mitochondrial respiration in Saccharomyces cerevisiae.

Authors:  Santhi Priya Inapurapu; Karunakar Rao Kudle; Sreedhar Bodiga; Vijaya Lakshmi Bodiga
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

5.  Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.

Authors:  Alois Kozubík; Alena Vaculová; Karel Soucek; Jan Vondrácek; Jaroslav Turánek; Jirina Hofmanová
Journal:  Met Based Drugs       Date:  2008

6.  Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells.

Authors:  S Seah; I C C Low; J L Hirpara; K Sachaphibulkij; G Kroemer; C Brenner; S Pervaiz
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.